A Study of mRNA-1018-H5 Pandemic Influenza Vaccine in Healthy Adults

Recruiting now · Phase 3 · Has a placebo group

Conditions studied: Influenza

In brief

The purpose of this study is to evaluate humoral immunogenicity after 2 doses of mRNA-1018-H5, and to evaluate the safety and reactogenicity of mRNA-1018-H5 in adults ≥18 years of age.

Key facts

Study ID
NCT07496450
Run by
ModernaTX, Inc.
People needed
4000
Starts
2026-03-23
Expected to finish
2027-01-28
Last updated by the study team
2026-04-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.